The Degenerative Dementias

[1]  L. Thal,et al.  Dementia and motor neuron disease: Morphometric, biochemical, and Golgi studies , 1984, Annals of neurology.

[2]  L. Thal,et al.  Klüver‐Bucy syndrome and amyotrophic lateral sclerosis , 1986, Neurology.

[3]  C. Lyketsos,et al.  Pharmacological treatment of neuropsychiatric symptoms of dementia. , 2005, JAMA.

[4]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[5]  D. Schaid,et al.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.

[6]  L. Wolfson,et al.  Clinico‐pathologic studies in dementia , 1988, Neurology.

[7]  C. Duyckaerts,et al.  Cortical tangles in progressive supranuclear palsy. , 1994, Journal of neural transmission. Supplementum.

[8]  F. Verhey,et al.  The Effect of Different Diagnostic Criteria on the Prevalence and Incidence of Post-Stroke Dementia , 2005, Neuroepidemiology.

[9]  D. Geldmacher,et al.  Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease , 2003, Journal of the American Geriatrics Society.

[10]  R. Scully,et al.  Case records of the Massachusetts General Hospital. , 1990 .

[11]  H. Wiśniewski,et al.  Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome , 1985, Annals of neurology.

[12]  Douglas Walker,et al.  Hippocampal Sclerosis Dementia with Tauopathy , 2003, Brain pathology.

[13]  J. Trojanowski,et al.  Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. , 2005, Journal of neuropathology and experimental neurology.

[14]  B. Boeve,et al.  Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy , 2001, Movement disorders : official journal of the Movement Disorder Society.

[15]  O. Lopez,et al.  Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease , 2005, Neurology.

[16]  S. Wisniewski,et al.  Predictors of progression in patients with AD and Lewy bodies , 2000, Neurology.

[17]  H J Testa,et al.  Progressive language disorder due to lobar atrophy , 1992, Annals of neurology.

[18]  H. Budka,et al.  Neocortical changes in Parkinson's disease, revisited. , 1994, Clinical neuropathology.

[19]  P. Visser,et al.  Predictive Accuracy of MCI Subtypes for Alzheimer’s Disease and Vascular Dementia in Subjects with Mild Cognitive Impairment: A 2-Year Follow-Up Study , 2005, Dementia and Geriatric Cognitive Disorders.

[20]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[21]  Douglas Galasko,et al.  Neuropsychological Deficits Associated with Diffuse Lewy Body Disease , 1996, Brain and Cognition.

[22]  John Breitner,et al.  Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. , 2003, Archives of neurology.

[23]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[24]  H. Brodaty,et al.  The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients , 2004, Neurology.

[25]  G. E. Smith,et al.  REM sleep behavior disorder and degenerative dementia , 1998, Neurology.

[26]  P. Ashby,et al.  Cortical‐basal ganglionic degeneration , 1990, Neurology.

[27]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[28]  V. Zaninovic.  SPASTIC PARAPARESIS: A POSSIBLE SEXUALLY TRANSMITTED VIRAL MYELONEUROPATHY , 1986, The Lancet.

[29]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[30]  Y Agid,et al.  Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. , 1985, Brain : a journal of neurology.

[31]  N Butters,et al.  Episodic memory changes are associated with the APOE- epsilon 4 allele in nondemented older adults , 1995, Neurology.

[32]  E. Tangalos,et al.  Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. , 2006, Archives of neurology.

[33]  B. Hyman,et al.  Alzheimer's disease with and without coexisting Parkinson's disease changes , 1995, Neurology.

[34]  L. Thal,et al.  Genetic-Evidence That the Lewy Body Variant Is Indeed a Phenotypic Variant of Alzheimers-Disease , 1995, Brain and Cognition.

[35]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[36]  L. Golbe.  The epidemiology of PSP. , 1994, Journal of neural transmission. Supplementum.

[37]  J. Rogers,et al.  Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease , 1992, Neurology.

[38]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[39]  L. Chang,et al.  Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease , 1995, Neurology.

[40]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[41]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[42]  J R Hodges,et al.  Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia. , 2004, Journal of neurology, neurosurgery, and psychiatry.

[43]  Walter Kukull,et al.  Progression to dementia in patients with isolated memory loss , 1997, The Lancet.

[44]  Joseph E Parisi,et al.  Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. , 2002, Archives of neurology.

[45]  M N Rossor,et al.  Progressive degeneration of the right temporal lobe studied with positron emission tomography. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[46]  L. Gustafson,et al.  Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. , 1987, Archives of gerontology and geriatrics.

[47]  Jennifer Farmer,et al.  Frontotemporal dementia: Clinicopathological correlations , 2006, Annals of neurology.

[48]  D. Drachman,et al.  Primary progressive aphasia with focal neuronal achromasia , 1991, Neurology.

[49]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[50]  J. Morris,et al.  Clinical phenotype of Parkinson disease dementia , 2006, Neurology.

[51]  D. Aarsland,et al.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.

[52]  D. Salmon,et al.  Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  D. Neary,et al.  Frontal lobe dementia and motor neuron disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[54]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[55]  R. Mayeux,et al.  Stroke and the risk of Alzheimer disease. , 2003, Archives of neurology.

[56]  N. Pachana,et al.  Alzheimer and vascular dementias and driving. A prospective road and laboratory study. , 1995, JAMA.

[57]  Jordan Grafman,et al.  A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia , 2006, Neurology.

[58]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[59]  B. Hyman,et al.  LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation , 1995, Cell.

[60]  P N Leigh,et al.  Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[61]  B. Hopcutt,et al.  Progressive aphasia without generalized dementia , 1990 .

[62]  A M Clarfield,et al.  The reversible dementias: do they reverse? , 1988, Annals of internal medicine.

[63]  K. Davis,et al.  Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. , 1994, Neuroreport.

[64]  R. Abbott,et al.  Walking and dementia in physically capable elderly men. , 2004, JAMA.

[65]  K. Heilman,et al.  Relative Frequencies of Alzheimer Disease, Lewy Body, Vascular and Frontotemporal Dementia, and Hippocampal Sclerosis in the State of Florida Brain Bank , 2002, Alzheimer disease and associated disorders.

[66]  I. McKeith,et al.  Clinical Lewy Body Syndromes , 2000, Annals of the New York Academy of Sciences.

[67]  Yaakov Stern,et al.  Mediterranean diet and risk for Alzheimer's disease , 2006, Annals of neurology.

[68]  D R Wekstein,et al.  Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.

[69]  T. Wetterling,et al.  Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). , 1996, Stroke.

[70]  L. Mucke,et al.  Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[71]  W. Brown,et al.  Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. , 1992, Brain : a journal of neurology.

[72]  M. Mesulam,et al.  Slowly progressive aphasia without generalized dementia , 1982, Annals of neurology.

[73]  J. Schneider,et al.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology , 2004, Neurology.

[74]  M. Freedman,et al.  Cognitive deficits in olivopontocerebellar atrophy: Implications for the cholinergic hypothesis of Alzheimer's dementia , 1988, Annals of neurology.

[75]  D. Bachman,et al.  Firearm Presence in Households of Patients with Alzheimer's Disease and Related Dementias , 1999, Journal of the American Geriatrics Society.

[76]  R. DeTeresa,et al.  Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.

[77]  B. H. Anderton,et al.  Dorothy Russell Memorial Lecture The molecular pathology of Alzheimer's disease: are we any closer to understanding the neurodegenerative process? , 1994, Neuropathology and applied neurobiology.

[78]  A. C. Stein,et al.  Practice parameter: Risk of driving and Alzheimer’s disease (an evidence-based review) , 2000, Neurology.

[79]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[80]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[81]  E. Tangalos,et al.  Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.

[82]  J. Blangero,et al.  Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. , 2000, Science.

[83]  W. Kukull,et al.  Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. , 2002, Archives of neurology.

[84]  J. Morris,et al.  Hereditary dysphasic dementia and the Pick‐Alzheimer spectrum , 1984, Annals of neurology.

[85]  A. Roses,et al.  Apolipoprotein E genotype and Lewy body disease , 1995, Neurology.

[86]  D. Mann,et al.  The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy , 2004, Acta Neuropathologica.

[87]  L. Kurland,et al.  Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features. , 1961, Brain : a journal of neurology.

[88]  S. Fahn,et al.  Parkinsonian features of eight pathologically diagnosed cases of diffuse lewy body disease , 1995, Movement disorders : official journal of the Movement Disorder Society.

[89]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[90]  W. Jagust,et al.  Clinical and Neuropsychological Features in Autopsy-Defined Vascular Dementia , 2004, The Clinical neuropsychologist.

[91]  R. Petersen,et al.  Rapidly progressive aphasic dementia and motor neuron disease , 1993, Annals of neurology.

[92]  M. Hutton,et al.  Phenotypic correlations in FTDP-17 , 2001, Neurobiology of Aging.

[93]  J. Avorn,et al.  Risk of death in elderly users of conventional vs. atypical antipsychotic medications. , 2005, The New England journal of medicine.

[94]  H. Soininen,et al.  Midlife vascular risk factors and late-life mild cognitive impairment , 2001, Neurology.

[95]  I. Shoulson,et al.  Clinical‐pathologic correlation in Huntington's disease , 1989, Neurology.

[96]  B. Ghetti,et al.  Progress in Hereditary Tauopathies: A Mutation in the Tau Gene (G389R) Causes a Pick Disease‐like Syndrome , 2000, Annals of the New York Academy of Sciences.

[97]  Joseph James Duffy,et al.  Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia , 2005, Neurocase.

[98]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[99]  D W Dickson,et al.  Widespread cytoskeletal pathology characterizes corticobasal degeneration. , 1995, The American journal of pathology.

[100]  H. Heinsen,et al.  Cortical and striatal neurone number in Huntington's disease , 2004, Acta Neuropathologica.

[101]  E. Granholm,et al.  Retrograde amnesia in patients with Alzheimer's disease or Huntington's disease , 1988, Neurobiology of Aging.

[102]  H. Vinters.  Neuropathology of amnestic mild cognitive impairment. , 2006, Archives of neurology.

[103]  Constantine Lyketsos,et al.  Dementia and Alzheimer's Disease Incidence in Relationship to Cardiovascular Disease in the Cardiovascular Health Study Cohort , 2005, Journal of the American Geriatrics Society.

[104]  L. Thal,et al.  Diagnostic accuracy of dementia with Lewy bodies. , 2000, Archives of neurology.

[105]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[106]  R. Petersen,et al.  Late-onset frontotemporal dementia associated with progressive supranuclear palsy/argyrophilic grain disease/Alzheimer’s disease pathology , 2005, Neurocase.

[107]  L. Farrer,et al.  Estimating the probability for major gene Alzheimer disease. , 1994, American journal of human genetics.

[108]  P. O'Brien,et al.  Epidemiology of dementia in Rochester, Minnesota. , 1996, Mayo Clinic proceedings.

[109]  D. Delis,et al.  Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. , 1990, Journal of clinical and experimental neuropsychology.

[110]  S. Gilman,et al.  Neuropsychological changes in olivopontocerebellar atrophy. , 1990, Archives of neurology.

[111]  M. Yoshimura.  Pathological basis for dementia in elderly patients with idiopathic Parkinson's disease. , 1988, European neurology.

[112]  R. Armstrong,et al.  Aluminium and Alzheimer's disease: review of possible pathogenic mechanisms. , 1996, Dementia.

[113]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[114]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease , 1995, Neurology.

[115]  A Brun,et al.  Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. , 1987, Archives of gerontology and geriatrics.

[116]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[117]  D. Selkoe,et al.  Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases , 1988, Annals of neurology.

[118]  J. Morrison,et al.  Balit's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway , 1989, Brain Research.

[119]  Kristine Yaffe,et al.  Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. , 2005, JAMA.

[120]  D. Murman,et al.  The impact of parkinsonism on costs of care in patients with AD and dementia with Lewy bodies , 2003, Neurology.

[121]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[122]  D. Benson.  Progressive aphasia: a case with postmortem correlation , 1991 .

[123]  M. N. Hart,et al.  Progressive aphasia in a patient with Pick's disease , 1990, Neurology.

[124]  G. Stelmach,et al.  Progressive apraxia in clinically discordant monozygotic twins. , 1995, Archives of neurology.

[125]  R. Petersen,et al.  REM sleep behavior disorder and dementia , 1999, Neurology.

[126]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[127]  D. Drachman,et al.  Driving and Alzheimer's disease , 1993, Neurology.

[128]  R. Weller,et al.  Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s disease Pro-CAA position statement , 2004, Neurobiology of Aging.

[129]  K. Marder,et al.  The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. , 1995, American journal of epidemiology.

[130]  G. C. Román,et al.  Vascular dementia , 1993, Neurology.

[131]  I. Litvan,et al.  Cognitive disturbances in progressive supranuclear palsy. , 1994, Journal of neural transmission. Supplementum.

[132]  R. Wolfert,et al.  Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease , 1995 .

[133]  P. Kehoe,et al.  Vascular risk and genetics of sporadic late-onset Alzheimer’s disease , 2004, Journal of Neural Transmission.

[134]  I. Shoulson,et al.  A prospective evaluation of cognitive decline in early Huntington's disease , 1995, Neurology.

[135]  R. Petersen,et al.  Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy , 2004, Neurology.

[136]  A. Hudson.  Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. , 1981, Brain : a journal of neurology.

[137]  A. Lang,et al.  Parietal Pick's disease mimicking cortical‐basal ganglionic degeneration , 1994, Neurology.

[138]  Jeffrey L. Cummings,et al.  Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2001 .

[139]  G. Fox,et al.  Alzheimer's Disease and Driving: Prediction and Assessment of Driving Performance , 1997, Journal of the American Geriatrics Society.

[140]  J. Lowe,et al.  The cortical neuritic pathology of Huntington's disease , 1995, Neuropathology and applied neurobiology.

[141]  K. Mizukami,et al.  Neuropathological study on the nucleus basalis of Meynert in Pick's disease , 2004, Acta Neuropathologica.

[142]  P. O'Brien,et al.  Risk Factors for Nursing Home Placement in a Population‐Based Dementia Cohort , 2000, Journal of the American Geriatrics Society.

[143]  J. Perlmutter,et al.  Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset. , 2002, Genomics.

[144]  M. Owen,et al.  Genetic studies on chromosome 12 in late-onset Alzheimer disease. , 1998, JAMA.

[145]  J. Berciano,et al.  Olivopontocerebellar atrophy A review of 117 cases , 1982, Journal of the Neurological Sciences.

[146]  R. Hichwa,et al.  Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function , 1988, Annals of neurology.

[147]  R. G. Feldman,et al.  Case 46-1993 , 1993 .

[148]  R. Caselli,et al.  Primary lateral sclerosis , 1995, Neurology.

[149]  C. Marsden,et al.  Movement disorder society symposium on cortical‐asal ganglionic degeneration (CBGD) and its relationship to other asymmetrical cortical degeneration syndromes (ACDs) washington, D. C. October 25–26, 1995 , 1996, Movement disorders : official journal of the Movement Disorder Society.

[150]  B. Boeve,et al.  Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. , 2000, Brain : a journal of neurology.

[151]  W. Jagust,et al.  Focal Alzheimer's disease , 1990, Neurology.

[152]  D. Drachman,et al.  Apolipoprotein E ε4 allele and the lifetime risk of Alzheimer's disease : what physicians know, and what they should know , 1995 .

[153]  J. Mazziotta,et al.  Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. , 1987, The New England journal of medicine.

[154]  C. Marsden,et al.  Clinical presentation and pharmacological therapy in corticobasal degeneration. , 1998, Archives of neurology.

[155]  D. Connor,et al.  Progressive Aphasia with Lewy Bodies , 2002, Dementia and Geriatric Cognitive Disorders.

[156]  B L Miller,et al.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.

[157]  H. Brewer,et al.  Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.

[158]  E. Richardson,et al.  Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. , 1967, Transactions of the American Neurological Association.

[159]  W. Jagust,et al.  Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability. , 2000, Archives of neurology.

[160]  J. Constantinidis,et al.  Pick’s Disease , 1974 .

[161]  G. V. Van Hoesen,et al.  Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.

[162]  E. Masliah,et al.  Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa , 1993, Journal of neuropathology and experimental neurology.

[163]  Catherine Lomen-Hoerth,et al.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.

[164]  D. Roth,et al.  Sustained benefit of supportive intervention for depressive symptoms in caregivers of patients with Alzheimer's disease. , 2004, The American journal of psychiatry.

[165]  P. Waser,et al.  The influence of taipoxin on cholinergic synapses in the electric organ ofTorpedo Marmorata , 2005, Journal of Neural Transmission.

[166]  A. Korczyn.  Mixed Dementia—the Most Common Cause of Dementia , 2002, Annals of the New York Academy of Sciences.

[167]  I. Kanazawa,et al.  Severe involvement of the ambient gyrus in a case of dementia with argyrophilic grain disease , 2002, Journal of the Neurological Sciences.

[168]  M. Rizzo,et al.  Simulated Car Crashes and Crash Predictors in Drivers With Alzheimer Disease , 1997 .

[169]  H. Kirshner,et al.  Progressive aphasia without dementia: Two cases with focal spongiform degeneration , 1987, Annals of neurology.

[170]  Lawrence S. Honig,et al.  Atherosclerosis and AD : Analysis of data from the US national Alzheimer's coordinating center. Author's reply , 2005 .

[171]  R. Mayeux,et al.  Heterogeneity in dementia of the Alzheimer type , 1985, Neurology.

[172]  Daniel J Schaid,et al.  Risk tables for parkinsonism and Parkinson's disease. , 2002, Journal of clinical epidemiology.

[173]  Irene Litvan,et al.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia , 2003, Annals of neurology.

[174]  M. Beal,et al.  The cortical lesion of Huntington's disease: Further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N‐methyl‐D‐aspartate lesions of rat cortex , 1992, Annals of neurology.

[175]  Y. Agid,et al.  Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy , 1991, Neurology.